About Elizabeth Oyekan, Senior Director, Quality & Population Health Solutions, Precision for Value

This author has not yet filled in any details.
So far Elizabeth Oyekan, Senior Director, Quality & Population Health Solutions, Precision for Value has created 3 blog entries.

Offensive or Defensive Drug Cost Strategies: Which Will Give Payers and Health Systems the Best Chance to Lower Drug Costs?

When it comes to winning in the effort to reduce rising drug costs, there are new offensive and defensive strategies in play. What works better in pharma? Does a good offense does beat a good defense?

Pathway to Success: Proposed CMS Changes to the MSSP ACO Program and Their Implications

After 6 years, CMS is proposing changes to the MSSP, with ACOs set to take on additional risk in an effort to reduce the cost of care to the delivery system and Medicare beneficiaries. Precision’s Elizabeth Oyekan examines the proposed Pathway to Success rule and its central tenet, the adoption of 2-sided risk models.

Pathways to Access: The Evolution of Medical Benefit Management Strategies

Elizabeth Oyekan, Senior Director, Quality and Population Health Solutions, explores the evolution of medical benefit management strategies and helps manufacturers understand where their products fit on clinical pathways—and how those pathways may differ by vendor.

By continuing to use our website, you agree to our use of cookies to help us give you the best experience, analyze your site usage, and assist in our marketing efforts.
For more information, or to learn how to change your cookies preferences, please click here.

OK